The Martini-Klinik am UKE GmbH is a highly specialized private clinic that has focused on the diagnosis, treatment, and research of prostate cancer since its founding in 2005. As a wholly-owned subsidiary of the University Medical Center Hamburg-Eppendorf (UKE), it offers a comprehensive range of treatment options, including classic open prostatectomy and minimally invasive robot-assisted surgery with the Da Vinci system[1][5].
The main mission of the Martini-Klinik is to effectively diagnose, treat, and research prostate cancer. The clinic's values are characterized by a high degree of specialization, quality, and patient orientation. By focusing on a single disease, the clinic can continuously optimize and improve its methods[4].
The Martini-Klinik is committed to sustainable and effective treatments that benefit both patients and the environment. Although specific sustainability goals are not explicitly mentioned, the focus is on long-term therapeutic success and continuous improvement of medical care. The clinic was even the subject of a Harvard Business School case study, which underscores its importance and innovative strength[5].
The Martini-Klinik has been under the management of Detlef Loppow as Managing Director since 2012. The clinic has made a name for itself through its high level of specialization and its ability to attract patients from all over the world. In 2019, for example, over 2,600 radical prostatectomies were performed, with almost nine percent of patients coming from abroad[5].
